TPA sales at wholesaler level
Executive Summary
Bergen-Brunswig sold 2,329 vials of Genentech's Activase in September, the lowest monthly volume since March when the distributor sold 2,215 vials. Bergen's December sales of TPA were its highest at 4,696 vials: sales tailed to 3,897 vials in April, dropping to 2,584 vials in August. In terms of sales to patients, and based on an average patient cost of approximately $ 2,300 per vial, Bergen Brunswig's sales of TPA this year through September were approximately $ 67 mil.